Navigation Links
Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award

BOZEN, Italy, October 12 /PRNewswire/ -- Health Robotics today announced the manufacturing, shipment, and subsequent field installation of the first five i.v.STATION post-prototype robots in the United States of America and in Spain within the September to November timeframe this year; concurrently, Health Robotics also made the announcement of its i.v.STATION robot's winning of the Area Science Park 3L 3T Innovation Award, which is given to the best technology product across all industries.

i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, and cost effective intravenous and ready-to-administer patient doses. It offers unprecedented reduction of medication errors, ISO compliant accuracy, sterility, and clinician labor savings, all within a scalable, cost-effective, distributed, and fail-safe architecture. The first 5 of 20 i.v.STATION installations are scheduled to begin at selected installations in Spain and the United States of America within the next four to five weeks.

During the ceremony celebrating the 3L 3T Innovation Award, Paolo Giribona, Director of Research of Development for Health Robotics stated: "After quite an intense summer we are very pleased both in winning the 3L 3T Innovation Award and with the initial results of i.v.STATION in laboratory and factory tests, quite sufficient in my opinion to feel confident about releasing i.v.STATION for installations this Fall, as we had planned all along after the results of two generation of prototypes we built in late 2008 and early 2009." For a transcript of the entire Q&A session with Paolo Giribona during the Award ceremony, please visit:

The primary challenges in today's IV Admixture operations are serious medication errors such as drug exchange and accuracy mistakes, high costs, life-critical turn-around time, intravenous drugs waste, regulatory issues, and difficulty in maintaining adequately trained clinical staff. i.v.STATION automatically and aseptically compounds non-hazardous IV doses and dispenses them to clinical staff in a ready-to-administer patient formats for antibiotics, pain therapy, anti-virals, epidurals, and other IVs and injectable medications. i.v.STATION was designed to address the above-mentioned industry-challenges, and to overcome the fact that until now, the range of products and technology available to mitigate these widespread industry patient safety and financial problems has consisted of variations on the IV "piggyback" bag, outsourcing of IVs, and 1990s-developed automated "solutions" that have seen little or no adoption and success over the past twenty years.

"These first five shipments of i.v.STATION represent the culmination of extraordinary work by our engineers and beta test customers and, I hope, also the start of a new era for Health Robotics in bringing our robots and software automation solutions out of the pharmacy basement and into the nurse stations [wards] and satellite pharmacies, as close as we can get to the patients. I feel bad for all of our 9 American beta test customers that have suffered delays solely due to the ill advised and frivolous litigation threats to their institutions by the distributor we terminated for cause in North America. We are nevertheless proceeding with installations at some of these 9 hospitals this month, while we will have no other choice but to substitute some of these 9 beta sites with other American hospitals, as solely decided by these 9 beta site hospitals on a case-by-case basis, based on their response to the litigation threats frivolously made against them by Devon Robotics. I also hope to announce our new partnership in North America for i.v.STATION over the next few weeks, but in any event before the ASHP Mid Year symposium in Las Vegas." stated Werner Rainer, Health Robotics' CEO.

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals' growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, please visit

    For additional information, please contact:
    Health Robotics S.r.l.
    Gaspar DeViedma
    Altmanstrasse 9A, Bozen, Sud-Tyrol, I-39100
    USA:    +1-609-980-7976
    EUROPE: +39-346-963-4934

SOURCE Health Robotics SRL

SOURCE Health Robotics SRL
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
2. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
3. Healthnostics Portal Web Site to Include Social Networking Features
4. Nanomedicine Company Focuses on Improving Premature Infant Health and Reducing Death Rate
5. avVaa World Health Care Products Inc. Announces DRTV Test Television Stations
6. GetReel Health and CheckOrphan Partner to Help Rare, Orphan and Neglected Diseases
7. avVaa World Health Care Products Inc. Announces Second DRTV Test Week
8. Healthnostics Unveils Biomedical Content Strategy for
9. Spain's Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season
10. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
11. Global Public Health the Focus of Scientific Conference
Post Your Comments:
(Date:11/26/2015)... 2015 ... Research Laboratories, a leading independent and ... has formed a strategic partnership with ... Health for joint work on clinical ... ) , --> ,     ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE ... has adopted a stockholder rights plan (Rights Plan) in ... operating loss carryforwards (NOLs) under Section 382 of the ... --> PharmAthene,s use of its NOLs could ... change" as defined in Section 382 of the Code. ...
(Date:11/25/2015)... and HOLLISTON, Mass. , Nov. ... (Nasdaq: HART ), a biotechnology company developing bioengineered ... Jim McGorry will present at the LD ... 2015 at 2:30 p.m. PT. The presentation will be ... 30 days. Management will also be available at the ...
(Date:11/25/2015)... ... November 25, 2015 , ... A long-standing ... Aerospace Professionals (OPBAP) has been formalized with the signing of a Memorandum of ... with OPBAP leaders Capt. Karl Minter and Capt. Albert Glenn Tuesday, November 24, ...
Breaking Biology Technology:
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
(Date:11/2/2015)... 2015  SRI International has been awarded a contract ... services to the National Cancer Institute (NCI) PREVENT Cancer ... expertise, modern testing and support facilities, and analytical instrumentation ... toxicology studies to evaluate potential cancer prevention drugs. ... Cancer Drug Development Program is an NCI-supported pipeline to ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
Breaking Biology News(10 mins):